支持,教育,授权个性化玻璃眼辅导计划对药物坚持的影响:SEE计划随机临床试验
Paula Anne Newman-Casey1, Leslie M Niziol1, Ming-Chen Lu1
1Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor.
JAMA ophthalmology
|February 26, 2026
概括
与标准教育相比,支持,教育,赋权 (SEE) 干预显著改善了对青光眼药物的坚持,并减少了患者的痛苦. 这项指导计划提供了基于证据的方法,以提高坚持和改善眼结局.
科学领域:
- 眼科医生 眼科 眼科
- 公共卫生 公共卫生
- 行为科学 行为科学
背景情况:
- 药物不服药是绿眼病患者视力丧失的主要原因.
- 提高坚持可以提高患者的结果,并减少医疗保健负担.
研究的目的:
- 为了比较支持,教育,赋权 (SEE) 干预措施与标准书面教育的有效性,以改善青光眼的药物坚持.
主要方法:
- 一个1: 1随机临床试验,涉及患有绿眼病和低自我报告的坚持的成年人.
- 东南欧的干预包括6个月的激励面试,健康指导和自动提醒.
- 药物坚持被电子监测;与玻璃眼相关的痛苦是次要结果.
主要成果:
- 与对照组 (58.0%) 相比,SEE干预组表现出明显更好的药物坚持 (77.6%).
- 东南欧国家集团中较高比例的参与者实现了80%的坚持 (54.9%与23.7%相比).
- 东南欧的干预也导致了与眼相关的痛苦的显著减少.
结论:
- 支持,教育,赋权 (SEE) 计划有效地改善了青光眼患者的药物坚持.
- 这种干预代表了一种可行的,基于证据的策略,以加强坚持并可能改善长期的青光眼管理和结果.
相关概念视频
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Angle Closure Glaucoma: Treatment
1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
Glaucoma: Overview
1.5K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
764
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
764
Blinding
4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
Ophthalmic Drug Delivery Systems
97
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
97


